» Articles » PMID: 10439837

CD40 Upregulation is Independent of HHV-8 in the Pathogenesis of Kaposi's Sarcoma

Overview
Journal Mol Pathol
Specialty Molecular Biology
Date 1999 Aug 10
PMID 10439837
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Human herpesvirus 8 (HHV-8) is now acknowledged as the infective cofactor in the pathogenesis of Kaposi's sarcoma. The mode by which HHV-8 causes Kaposi's sarcoma is unresolved and it is probable that it acts in conjunction with other factors including cytokines, anti-apoptosis proteins, and cell surface receptors. CD40, a cell membrane receptor belonging to the tumour necrosis factor receptor super family, promotes B cell survival and is expressed constitutively on endothelial cells. It is upregulated on cytokine treatment and has been documented recently in Kaposi's sarcoma. Because the HHV-8 genome contains cytokine homologues, this study investigated whether CD40 expression in Kaposi's sarcoma correlated with HHV-8 status, using a unique set of HHV-8 positive and negative specimens.

Methods: Twenty one paraffin wax embedded samples of Kaposi's sarcoma were selected, of which 18 were screened for the presence of HHV-8 using both conventional solution phase and TaqMan polymerase chain reaction (PCR). CD40 immunohistochemistry was assessed using a biotinylated amplification system. Staining was scored semiquantitatively.

Results: The results indicated that the expression of CD40 is independent of viral status, being present in both HHV-8 positive and negative specimens.

Conclusions: This suggests that HHV-8 promotes Kaposi's sarcoma cell survival following infection by mechanisms other than those involving CD40.

Citing Articles

Real-time Fluorescent PCR Techniques to Study Microbial-Host Interactions.

Mackay I, Arden K, Nitsche A Methods Microbiol. 2024; 34:255-330.

PMID: 38620210 PMC: 7148886. DOI: 10.1016/S0580-9517(04)34010-9.


Candidate Biomarkers for Specific Intraoperative Near-Infrared Imaging of Soft Tissue Sarcomas: A Systematic Review.

Rijs Z, Shifai A, Bosma S, Kuppen P, Vahrmeijer A, Keereweer S Cancers (Basel). 2021; 13(3).

PMID: 33535618 PMC: 7867119. DOI: 10.3390/cancers13030557.


Real-time PCR in virology.

Mackay I, Arden K, Nitsche A Nucleic Acids Res. 2002; 30(6):1292-305.

PMID: 11884626 PMC: 101343. DOI: 10.1093/nar/30.6.1292.

References
1.
Merz H, Malisius R, Mannweiler S, Zhou R, Hartmann W, Orscheschek K . ImmunoMax. A maximized immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab Invest. 1995; 73(1):149-56. View

2.
Karmann K, Hughes C, Schechner J, Fanslow W, Pober J . CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A. 1995; 92(10):4342-6. PMC: 41940. DOI: 10.1073/pnas.92.10.4342. View

3.
Soulier J, GROLLET L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P . Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995; 86(4):1276-80. View

4.
Moore P, Gao S, Dominguez G, Cesarman E, Lungu O, Knowles D . Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol. 1996; 70(1):549-58. PMC: 189843. DOI: 10.1128/JVI.70.1.549-558.1996. View

5.
Chang Y, Ziegler J, Wabinga H, Boshoff C, Schulz T, Whitby D . Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med. 1996; 156(2):202-4. View